Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer

Name: Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer
License: Public Domain

The Methodist Hospital Research Institute

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

urothelial carcinoma bladder

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 674775
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.